Research Article
Evaluation of Hepatic Mitochondria and Hematological Parameters in Zidovudine-Treated Mice
Table 1
Levels of hematological parameters in B6C3F1 mice.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
aindicates a significant () difference in hematological parameter at 11-week compared to 0-week for each sex. bindicates a significant () sex-based difference in hematological parameter in female mice compared to male counterparts at 11-week. Values are presented as the mean ± SEM (–6). Also, a significant () dose-related response was noted in the RBC count, Hb content, MCV, and MCH level in both sexes. |